Literature DB >> 2859269

Genetic analysis of the phase variation control of expression of type 1 fimbriae in Escherichia coli.

C S Freitag, J M Abraham, J R Clements, B I Eisenstein.   

Abstract

Expression of type 1 fimbriae in Escherichia coli exhibits phase variation, whereby individual cells can alternate between states of organelle expression (Fim+) and nonexpression (Fim-). Strains with a fimD-lac operon fusion, in which lac, rather than fimD, expression is under the control of the fimD promoter, undergo Lac+ in equilibrium Lac- phase variation, instead. After positioning a lambda prophage adjacent to the operon fusion, we were able to isolate specialized lambda phage carrying both the fimD-lac fusion and the phase variation control region. Introduction of such phage into an Fim+ strain resulted in construction of a strain with a double, independently switching phenotype (Fim+ in equilibrium Fim- and Lac+ in equilibrium Lac-), demonstrating that the region controlling phase variation is contiguous with the fimD-lac operon fusion and is cis acting. When the specialized lambda phage was propagated on a delta lac delta fim strain, phase variation occurred within the plaques, confirming that the phase variation control region is carried on the specialized transducing phage. All lysogens acquired the Lac+ in equilibrium Lac- phenotype, except for two nonswitching Lac+ recombinants, which acquired Lac+ in equilibrium Lac- phase variation only by trans complementation with fim. Phase variation of type 1 fimbriae, therefore, appears to involve both a cis-active element, which is cloned on a specialized lambda phage, and a trans-active permissive factor, which is not present on the phage, but rather must be supplied by the recipient strain in the transduction.

Entities:  

Mesh:

Year:  1985        PMID: 2859269      PMCID: PMC218902          DOI: 10.1128/jb.162.2.668-675.1985

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  28 in total

1.  Non-flagellar appendages of bacteria.

Authors:  C C BRINTON
Journal:  Nature       Date:  1959-03-21       Impact factor: 49.962

2.  Properties of the translocatable tetracycline-resistance element Tn10 in Escherichia coli and bacteriophage lambda.

Authors:  N Kleckner; D F Barker; D G Ross; D Botstein
Journal:  Genetics       Date:  1978-11       Impact factor: 4.562

3.  Mannose residues on phagocytes as receptors for the attachment of Escherichia coli and Salmonella typhi.

Authors:  Z Bar-Shavit; I Ofek; R Goldman; D Mirelman; N Sharon
Journal:  Biochem Biophys Res Commun       Date:  1977-09-09       Impact factor: 3.575

4.  Pilus genes of Neisseria gonorrheae: chromosomal organization and DNA sequence.

Authors:  T F Meyer; E Billyard; R Haas; S Storzbach; M So
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

5.  Transposition and fusion of the lac genes to selected promoters in Escherichia coli using bacteriophage lambda and Mu.

Authors:  M J Casadaban
Journal:  J Mol Biol       Date:  1976-07-05       Impact factor: 5.469

6.  Regulation of gene expression by site-specific inversion.

Authors:  J Zieg; M Hilmen; M Simon
Journal:  Cell       Date:  1978-09       Impact factor: 41.582

7.  A Mu gin complementing function and an invertible DNA region in Escherichia coli K-12 are situated on the genetic element e14.

Authors:  P van de Putte; R Plasterk; A Kuijpers
Journal:  J Bacteriol       Date:  1984-05       Impact factor: 3.490

8.  Organization and expression of genes responsible for type 1 piliation in Escherichia coli.

Authors:  P E Orndorff; S Falkow
Journal:  J Bacteriol       Date:  1984-08       Impact factor: 3.490

9.  Identification and characterization of a gene product that regulates type 1 piliation in Escherichia coli.

Authors:  P E Orndorff; S Falkow
Journal:  J Bacteriol       Date:  1984-10       Impact factor: 3.490

10.  Type I Escherichia coli pili: characterization of binding to monkey kidney cells.

Authors:  I E Salit; E C Gotschlich
Journal:  J Exp Med       Date:  1977-11-01       Impact factor: 14.307

View more
  41 in total

1.  Antigen 43 and type 1 fimbriae determine colony morphology of Escherichia coli K-12.

Authors:  H Hasman; M A Schembri; P Klemm
Journal:  J Bacteriol       Date:  2000-02       Impact factor: 3.490

2.  Rapid site-specific DNA inversion in Escherichia coli mutants lacking the histonelike protein H-NS.

Authors:  T H Kawula; P E Orndorff
Journal:  J Bacteriol       Date:  1991-07       Impact factor: 3.490

3.  Type 1 fimbriation and fimE mutants of Escherichia coli K-12.

Authors:  I C Blomfield; M S McClain; J A Princ; P J Calie; B I Eisenstein
Journal:  J Bacteriol       Date:  1991-09       Impact factor: 3.490

4.  Roles of fimB and fimE in site-specific DNA inversion associated with phase variation of type 1 fimbriae in Escherichia coli.

Authors:  M S McClain; I C Blomfield; B I Eisenstein
Journal:  J Bacteriol       Date:  1991-09       Impact factor: 3.490

Review 5.  Bacterial virulence: an environmental response.

Authors:  J S Kroll
Journal:  Arch Dis Child       Date:  1991-03       Impact factor: 3.791

Review 6.  Linkage map of Escherichia coli K-12, edition 10: the traditional map.

Authors:  M K Berlyn
Journal:  Microbiol Mol Biol Rev       Date:  1998-09       Impact factor: 11.056

Review 7.  Linkage map of Escherichia coli K-12, edition 8.

Authors:  B J Bachmann
Journal:  Microbiol Rev       Date:  1990-06

8.  IscR controls iron-dependent biofilm formation in Escherichia coli by regulating type I fimbria expression.

Authors:  Yun Wu; F Wayne Outten
Journal:  J Bacteriol       Date:  2008-12-12       Impact factor: 3.490

Review 9.  The leucine-responsive regulatory protein, a global regulator of metabolism in Escherichia coli.

Authors:  J M Calvo; R G Matthews
Journal:  Microbiol Rev       Date:  1994-09

10.  Type 1 fimbriae, a colonization factor of uropathogenic Escherichia coli, are controlled by the metabolic sensor CRP-cAMP.

Authors:  Claudia M Müller; Anna Aberg; Jurate Straseviçiene; Levente Emody; Bernt Eric Uhlin; Carlos Balsalobre
Journal:  PLoS Pathog       Date:  2009-02-20       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.